RECRUITING

Technology Enabled Strategies to Promote Treatment Adherence in Liver Transplant

Talk to us

Conditions

Liver Transplant; ComplicationsCirrhosisEnd Stage Liver DIseaseMedication Adherence

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Liver transplantation is increasingly performed for older adults with multiple comorbidities. Medication adherence is key to maintaining proper function of the transplanted liver and optimize health; however, adhering to post-transplant treatment is complex. This trial will study how available technology combined with transplant center resources and caregiver support can optimize medication adherence, quality of life, and health outcomes among new liver transplant recipients at 3 centers.

Official Title

Technology Enabled Strategies to Promote Treatment Adherence in Liver Transplant

Quick Facts

Study Start:2022-12-01
Study Completion:2027-01-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05260268

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * 18 years or older
  2. * Within 3 months of liver transplant
  3. * English or Spanish-speaking
  4. * Home-dwelling\*
  5. * Patient or care partner owns a smart phone and is comfortable receiving text messages and/or using the internet on the smart phone.
  6. * \*The definition of "home" includes hotel or short-term housing. Patients who are going to a rehabilitation or skilled nursing facility (SNF) immediately after transplant may still be recruited if the site-PI/Co-I determines they are likely to be discharged to home within 3 months post-transplant.
  1. * Liver transplant recipient who speaks neither English nor Spanish
  2. * Any severe uncorrectable vision, hearing, or cognitive impairments that may impede study interviews

Contacts and Locations

Study Contact

Richard Mason, PharmD
CONTACT
(215) 662-3904
richard.mason@pennmedicine.upenn.edu
Marina Serper, MD
CONTACT
(215) 349-8222
marinas2@pennmedicine.upenn.edu

Principal Investigator

Marina Serper, MD
PRINCIPAL_INVESTIGATOR
University of Pennsylvania

Study Locations (Sites)

University of Miami
Miami, Florida, 33146
United States
Northwestern University
Chicago, Illinois, 60208
United States
University of Pennsylvania
Philadelphia, Pennsylvania, 19104
United States

Collaborators and Investigators

Sponsor: University of Pennsylvania

  • Marina Serper, MD, PRINCIPAL_INVESTIGATOR, University of Pennsylvania

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-12-01
Study Completion Date2027-01-01

Study Record Updates

Study Start Date2022-12-01
Study Completion Date2027-01-01

Terms related to this study

Additional Relevant MeSH Terms

  • Liver Transplant; Complications
  • Cirrhosis
  • End Stage Liver DIsease
  • Medication Adherence